Rightway, First PBM Integrates with Mark Cuban's Cost Plus Drugs Company

Article

The integration into Rightway's modern PBM combines the transparent pricing of Cost Plus Drugs with Rightway's signature member experience, granting members direct access to the pharmacy.

Mark Cuban's drug company, Cost Plus Drugs, has added healthcare company Rightway to its network. This marks the first time a Pharmacy Benefit Manager (PBM) has added the pharmacy to its network.

This relationship grants members of Rightway's PBM direct access to all medications available through Cost Plus Drugs, according to a news release.

Rising pharmacy costs are one of the fastest-growing components employers are seeing within their companies. PBMs are leaving employers and patients with few options to curb rising costs.

Cost Plus Drugs has built a parallel supply chain, sidestepping the limitations of the current PBM landscape altogether and unlocking an unprecedented level of transparency, flexibility and availability for consumers to fill their generic prescriptions. The prices at Cost Plus Drugs are at cost with a 15% markup. Prescriptions are delivered by mail, further lowering the cost per pill as mail-order medications are dispensed in greater quantities.

The integration into Rightway's modern PBM combines the transparent pricing of Cost Plus Drugs with Rightway's signature member experience, granting members direct access to the pharmacy from within the Rightway mobile app.

"Rightway's relationship with Cost Plus Drugs demonstrates our commitment to making it as easy as possible for members to get the absolute lowest price available for their prescriptions," said Scott Musial, Chief Pharmacy Officer of Rightway, in the release. "Cost Plus Drugs offers some of the lowest prices in the market. It enables Rightway to step away from the traditional supply chain, offering our members greater choice, lowering their spending, and giving them back time they'd spend at the pharmacy. Entrants like Cost Plus Drugs are welcome warriors in the battle against sky-high drug prices."

Recent Videos
Jill Zouzoulas, MD, FACR, an expert on biologic therapies
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 5 - "Obstacles in Adapting Diabetes Technology to Individual Needs" - 1 KOL is featured
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Lawrence Eichenfield, MD, an expert on atopic dermatitis
Video 4 - "The Impact of Continuous Glucose Monitors & Digital Solutions on Diabetes Care"
Video 3 - "The Pivotal Role of Patient Engagement and Education in Achieving Optimal Diabetes Outcomes"
Related Content
© 2024 MJH Life Sciences

All rights reserved.